December 2016

Of the handful of companies conducting clinical trials on cannabinoids, AXIM® Biotechnologies (OTC: AXIM), which was recently featured in Fox Business, has positioned itself as one to watch. Founded in 2010, innovative biotechnology company AXIM Biotech has set the standard for cannabinoid bioscience through the discovery and commercialization of cannabinoid-based pharmaceuticals and supplements. With AXIM […]

by

Marijuana Legalization in USA Triggering Keen Investor Interest $GWPH, $INSY, $CARA, $MON, $ADM Marijuana legalization in the USA has brought keen interest among investors seeking to profit from a growing and very valuable cash crop. The states of California, Nevada, Massachusetts, Maine, Florida, North Dakota, Arkansas and Montana have approved measures to allow the Medical […]

by

You may have been told that having a glass of milk before bed can help you sleep, but this milk promises more. Metro reports that Rawligion is set to release Relax, their cannabidiol milk, on November 1st through pharmaceutical companies. The anxiety, pain, and stress reducing cocktail is a 100% vegan and organic blend of […]

by

ZYN002 CBD gel was shown to be safe and well-tolerated across range of doses tested in healthy subjects and adult epilepsy patients with focal seizuresNo impairment in cognitive performance or changes in psychological health were observed DEVON, Pa., Dec. 05, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (ZYNE), a clinical-stage specialty pharmaceutical company dedicated to […]

by

(Reuters) – BioCryst Pharmaceuticals Inc said on Monday a dose of its experimental antiviral drug improved survival rates in mice infected with the Zika virus in a preclinical study. Two doses of the drug, BCX443, were tested against a placebo and an oral antiviral called ribavarin for their effect on survival of immune-deficient mice infected […]

by

Shares of Synthetics Biologics, Inc. (NYSEMKT:SYN) added 3.59% by the end of trading session at $0.86. For the current quarter, the 5 brokerage firms issuing adjusted earnings per share outlook have a consensus forecast of -$0.08/share, which would compare with -$0.12 in the year-ago quarter. The net percentage change is -65.52% over the last 12 […]

by

[ACCESSWIRE] COSTA MESA, CA / ACCESSWIRE / December 20, 2016 / NEMUS Bioscience, Inc. (OTCQB: NMUS) announced it has signed a definitive license agreement for rights to Teewinot Life Sciences Corp.’s patented biosynthetic technology to produce NEMUS’ proprietary cannabinoid molecules. “Nemus is anticipating an era of hypergrowth in the pharmaceuticalized cannabinoid space and we believe […]

by

[ACCESSWIRE] COSTA MESA, CA / ACCESSWIRE / December 20, 2016 / NEMUS Bioscience, Inc. (OTCQB: NMUS) announced it has signed a definitive license agreement for rights to Teewinot Life Sciences Corp.’s patented biosynthetic technology to produce NEMUS’ proprietary cannabinoid molecules. “Nemus is anticipating an era of hypergrowth in the pharmaceuticalized cannabinoid space and we believe […]

by

Kiva Confections, a Californian medical cannabis company, has just introduced its new chocolate bars high in cannabidiol (CBD) and made from 100 percent whole plant cannabis. Recent anecdotal research has shown CBD to be an effective agent against systemic lupus erythematosus (SLE) and many other diseases. CBD and tetrahydrocannabinol (THC) are the two main ingredients of the […]

by